Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging

Abdominal Radiology

Volumn 42, Issue 2, 2017, Pages 468-477

  França, Manuela ^a   Martí Bonmatí, Luis ^b   Alberich Bayarri, Ángel ^b   Oliveira, Pedro ^c   Guimaraes, Susana ^d   Oliveira, João ^a   Amorim, João ^a   Gonzalez, Javier Sanchez ^e   Vizcaíno, José Ramón ^a   Miranda, Helena Pessegueiro ^a,c  

^a Institute of Biomedical Sciences Abel Salazar   (Portugal)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

^d Universidade do Porto   (Portugal)

^e PHILIPS HEALTHCARE   (United States)

Author keywords

Diffusion weighted imaging; Intravoxel incoherent motion; Iron overload; Liver fibrosis; Liver steatosis; Magnetic resonance

Indexed keywords

IRON;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSE LIVER DISEASE; DIFFUSION WEIGHTED IMAGING; FATTY LIVER; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVOXEL INCOHERENT MOTION DIFFUSION DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING; IRON OVERLOAD; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDEROSIS; BIOPSY; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; INFLAMMATION; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY;

ADULT; BIOPSY; DIFFUSION MAGNETIC RESONANCE IMAGING; FATTY LIVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFLAMMATION; IRON OVERLOAD; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84987618018     PISSN: 2366004X     EISSN: 23660058     Source Type: Journal    
DOI: 10.1007/s00261-016-0899-0     Document Type: Article

References (39)

1. Ellis EL, Mann DA (2012) Clinical evidence for the regression of liver fibrosis. J Hepatol 56:1171–1180. doi:10.1016/j.jhep.2011.09.024
2. Myers RP, Fong A, Shaheen AAM (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 28:705–712. doi:10.1111/j.1478-3231.2008.01691.x
3. Bedossa P, Dargère D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457. doi:10.1016/j.hep.2003.09.022
4. Lewin MM, Poujol-Robert AA, Boëlle P-YP, et al. (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665. doi:10.1002/hep.21747
5. Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: Intravoxel incoherent motion MR Imaging—Pilot Study. Radiology 249:891–899. doi:10.1148/radiol.2493080080
6. Taouli B, Tolia AJ, Losada M, et al. (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799–806. doi:10.2214/AJR.07.2086
7. Taouli B, Chouli M, Martin AJ, et al. (2008) Chronic hepatitis: Role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28:89–95. doi:10.1002/jmri.21227
8. Sandrasegaran K, Akisik FM, Lin C, et al. (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193:1556–1560. doi:10.2214/AJR.09.2436
9. Bakan AA, Inci E, Bakan S, et al. (2011) Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol 22:682–687. doi:10.1007/s00330-011-2295-z
10. Taouli B, Koh DM (2009) Diffusion-weighted MR Imaging of the Liver. Radiology 254:47–66. doi:10.1148/radiol.09090021
11. Yamada I, Aung W, Himeno Y, et al. (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210:617–623
12. Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505. doi:10.1148/radiology.168.2.3393671
13. Yoon JH, Lee JM, Baek JH, et al. (2014) Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 38:110–116. doi:10.1097/RCT.0b013e3182a589be
14. Lu P-X, Huang H, Yuan J, et al. (2014) Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: A prospective clinical intravoxel incoherent motion MR imaging study. PLoS One 9:e113846. doi:10.1371/journal.pone.0113846.t002
15. Hu G, Chan Q, Quan X, et al. (2014) Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model. J Magn Reson Imaging 42:331–339. doi:10.1002/jmri.24796
16. Chow AM, Gao DS, Fan SJ, et al. (2012) Liver fibrosis: an intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 36:159–167. doi:10.1002/jmri.23607
17. Chung SR, Lee SS, Kim N, et al. (2014) Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. Acta Radiol 56:1428–1436. doi:10.1177/0284185114559763
18. Zhang Y, Jin N, Deng J, et al. (2013) Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis. Magn Reson Imaging 31:1017–1021. doi:10.1016/j.mri.2013.03.007
19. Saxena R (2011) Microscopic anatomy, basic terms, and elemental lesions. In: Saxena R (ed) Practical hepatic pathology: a diagnostic approach, 1st edn. Philadelphia: Elsevier Saunders, pp 3–28
20. Wang Q-B, Zhu H, Liu H-L, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239–247. doi:10.1002/hep.25610
21. Tosun M, Inan N, Sarisoy HT, et al. (2013) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82:203–207. doi:10.1016/j.ejrad.2012.09.009
22. Fujimoto K, Tonan T, Azuma S, et al. (2011) Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology 258:739–748. doi:10.1148/radiol.10100853
23. Bülow R, Mensel B, Meffert P, et al. (2012) Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol 23:1281–1287. doi:10.1007/s00330-012-2700-2
24. Guiu B, Petit JM, Capitan V, et al. (2012) Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR Study. Radiology 265:96–103. doi:10.1148/radiol.12112478
25. Lee JT, Liau J, Murphy P, et al. (2012) Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. Magn Reson Imaging 30:572–578. doi:10.1016/j.mri.2011.12.013
26. Hansmann J, Hernando D, Reeder SB (2012) Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med 69:545–552. doi:10.1002/mrm.24535
27. Leitão HS, Doblas S, d’Assignies G, et al. (2012) Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis. Eur Radiol 23:461–467. doi:10.1007/s00330-012-2626-8
28. Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699
29. Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321. doi:10.1002/hep.20701
30. Deugnier Y, Turlin B (2007) Pathology of hepatic iron overload. WJG 13:4755–4760
31. Papalavrentios L, Sinakos E, Chourmouzi D, et al. (2015) Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis. Ann Gastroenterol 28:118–123
32. Bonekamp S, Torbenson MS, Kamel IR (2011) Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 45:885–892. doi:10.1097/MCG.0b013e318223bd2c
33. Patel J, Sigmund EE, Rusinek H, et al. (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: Preliminary experience. J Magn Reson Imaging 31:589–600. doi:10.1002/jmri.22081
34. Murphy P, Hooker J, Ang B, et al. (2014) Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. J Magn Reson Imaging 41:1629–1638. doi:10.1002/jmri.24755
35. Parente DB, Paiva FF, Oliveira Neto JA, et al. (2015) Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients. PLoS One 10:e0125653. doi:10.1371/journal.pone.0125653.t004
36. Chandarana H, Do RKG, Mussi TC, et al. (2012) The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis. AJR Am J Roentgenol 199:803–808. doi:10.2214/AJR.11.7541
37. Leporq B, Saint-Jalmes H, Rabrait C, et al. (2015) Optimization of intra-voxel incoherent motion imaging at 3.0 Tesla for fast liver examination. J Magn Reson Imaging 41:1209–1217. doi:10.1002/jmri.24693
38. Andreou A, Koh DM, Collins DJ, et al. (2012) Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 23:428–434. doi:10.1007/s00330-012-2604-1
39. Desmet VJ (2003) Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431–435]. J Hepatol 38:382–386. doi:10.1016/S0168-8278(03)00005-9